(Q34239823)

31 July 2017

1 reference

title

Angiotensin, fibrinolysis, and vascular homeostasis (English)

1 reference

31 July 2017

Vaughan DE

1

1 reference

PubMed ID

11334764

31 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

American Journal of Cardiology

31 July 2017

1 reference

31 July 2017

87

1 reference

31 July 2017

18C-24C

1 reference

31 July 2017

8A

1 reference

Role of the fibrinolytic system in preventing myocardial infarction

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Interaction of one-chain and two-chain tissue plasminogen activator with intact and plasmin-degraded fibrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Vascular-bed--specific hemostasis and hypercoagulable states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

The role of plasminogen activation in smooth muscle cell migration after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Circadian Variation of Fibrinolytic Activity in Blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Circadian variation in the frequency of onset of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Prospective study of endogenous tissue plasminogen activator and risk of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Implications of local angiotensin production in cardiovascular physiology and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Role of bradykinin in mediating vascular effects of angiotensin-converting enzyme inhibitors in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Role of endogenous bradykinin in human coronary vasomotor control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Bradykinin stimulates tissue plasminogen activator release in human vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

The role of nitric oxide in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Endothelial dysfunction: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Cardiac Angiotensin II Receptors Are Upregulated by Long-Term Inhibition of Nitric Oxide Synthesis in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

Plasminogen activator inhibitors--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901509-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(01)01509-0

1 reference

31 July 2017

1 reference

PubMed ID

11334764